fluorouracil has been researched along with thymoquinone in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 5 (55.56) | 24.3611 |
2020's | 2 (22.22) | 2.80 |
Authors | Studies |
---|---|
Liu, HY; Sun, J; Xu, RF; Zhu, HL | 1 |
Benghuzzi, H; May, M; Norwood, AA; Tan, M; Tucci, M | 1 |
Benghuzzi, H; Norwood, AA; Tucci, M | 1 |
Dong, W; Guo, X; Ji, M; Lei, X; Liu, M; Lv, X; Yang, Z | 1 |
Bayram, R; Benek, SB; Sarman, H | 1 |
Ahmad, J; El-Shemi, AG; Idris, S; Kensara, OA; Mohamed, AM; Refaat, B | 1 |
Agaimy, A; Ballout, F; Çapci, A; Chanvorachote, P; El-Baba, C; Erlenbach-Wuensch, K; Gali-Muhtasib, H; Geppert, CI; Hartmann, A; Huebner, K; Klein, V; Muenzner, JK; Ndreshkjana, B; Roehe, AV; Schneider-Stock, R; Steinmann, S; Tsogoeva, SB | 1 |
Chen, HC; Fu, J; Junaid, M; Khan, MA; Mei, Z; Tania, M; Zheng, M | 1 |
Hosseini, SM; Kazemi, S; Lotfi, M; Madani, F; Moghadamnia, AA; Shirafkan, F | 1 |
9 other study(ies) available for fluorouracil and thymoquinone
Article | Year |
---|---|
Identification of nitroimidazole-oxime derivatives targeting the polo-box domain of polo-like kinase 1.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle Proteins; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Docking Simulation; Molecular Structure; Nitroimidazoles; Oximes; Polo-Like Kinase 1; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Structure-Activity Relationship; Tumor Cells, Cultured | 2017 |
Comparison of potential chemotherapeutic agents, 5-fluoruracil, green tea, and thymoquinone on colon cancer cells.
Topics: Antineoplastic Agents; Benzoquinones; Catechin; Cell Proliferation; Cell Survival; Colonic Neoplasms; Dose-Response Relationship, Drug; Feasibility Studies; Fluorouracil; Plant Extracts; Tea; Treatment Outcome | 2006 |
A comparison of 5-fluorouracil and natural chemotherapeutic agents, EGCG and thymoquinone, delivered by sustained drug delivery on colon cancer cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Benzoquinones; Catechin; Cell Proliferation; Cell Survival; Colonic Neoplasms; Delayed-Action Preparations; Dose-Response Relationship, Drug; Fluorouracil; Humans; Phytotherapy; Plant Extracts; Treatment Outcome; Tumor Cells, Cultured | 2007 |
Thymoquinone inhibits growth and augments 5-fluorouracil-induced apoptosis in gastric cancer cells both in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Benzoquinones; Drug Resistance, Neoplasm; Female; Fluorouracil; Humans; Mice; Mice, Inbred BALB C; Stomach Neoplasms; Xenograft Model Antitumor Assays | 2012 |
Anticancer drugs with chemotherapeutic interactions with thymoquinone in osteosarcoma cells.
Topics: Antineoplastic Agents; Apoptosis; Benzoquinones; Bone Neoplasms; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Interactions; Fluorouracil; Humans; Organoplatinum Compounds; Osteosarcoma; Oxaliplatin; Tumor Cells, Cultured | 2016 |
Thymoquinone subdues tumor growth and potentiates the chemopreventive effect of 5-fluorouracil on the early stages of colorectal carcinogenesis in rats.
Topics: Animals; Anticarcinogenic Agents; Benzoquinones; Carcinogenesis; Cell Proliferation; Colonic Neoplasms; Fluorouracil; Male; Rats, Wistar | 2016 |
Combination of 5-fluorouracil and thymoquinone targets stem cell gene signature in colorectal cancer cells.
Topics: AC133 Antigen; Animals; Benzoquinones; beta Catenin; Cell Adhesion; Chick Embryo; Colorectal Neoplasms; Cytotoxins; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Mice; Neoplastic Stem Cells; Organoids; Xenograft Model Antitumor Assays | 2019 |
Synergistic Role of Thymoquinone on Anticancer Activity of 5-Fluorouracil in Triple Negative Breast Cancer Cells.
Topics: Apoptosis; Benzoquinones; Cell Line, Tumor; Cell Proliferation; Fluorouracil; Humans; Triple Negative Breast Neoplasms | 2022 |
Thymoquinone protects against 5-Fluorouracil-induced mucositis by NF-κβ and HIF-1 mechanisms in mice.
Topics: Animals; Antineoplastic Agents; Antioxidants; Fluorouracil; Mice; Mucositis; Oxidative Stress | 2023 |